Editorials |
From the Laboratory of Biochemical Genetics and Metabolism, The Rockefeller University, New York, NY 10021
Correspondence to Ephraim Sehayek, Laboratory of Biochemical Genetics and Metabolism, The Rockefeller University, 1230 York Avenue, New York, NY 10021. Email sehayee@rockefeller.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
The disorder Phytoterolemia is characterized by
50-fold elevations in plasma plant sterol levels as well as tendon xanthomas and premature coronary heart disease.1 On pathological examination the xanthomas and arteries of these patients contain plant sterols.2 This has raised questions of whether plant sterols are proatherogenic and whether the "normal" variation of plasma plant sterol levels in the general population is a risk factor for coronary heart disease. The article by Wilund et al in the December 2004 issue of Arteriosclerosis, Thrombosis, and Vascular Biology attempts to answer both questions through a mouse atherosclerosis study and an epidemiological study.3
See December 2004, page 2326
Phytosterolemia is an autosomal recessive disease, which results from mutations in one or both of two adjacent genes, ABCG5 and ABCG8.4,5 These genes encode hemi transporters that regulate plasma plant sterol levels by limiting intestinal plant sterol absorption and promoting biliary plant sterol excretion. It is not entirely clear that the elevated plant sterols in Phytosterolemics account for their premature coronary heart disease, because some patients also have very high plasma cholesterol levels in early childhood and most adults with the disorder have moderately elevated plasma cholesterol levels. Therefore, it could be the associated hypercholesterolemia, rather than the elevated plasma plant sterol levels, that is responsible for the premature coronary heart disease.
Plasma plant sterols cannot be synthesized endogenously and are completely derived from the diet. In Western populations, the major plasma plant sterols are campesterol (
0.33 mg/dL) and sitosterol (
0.25 mg/dL), with
This article has been cited by other articles:
![]() |
S Kidambi and S B Patel Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis J. Clin. Pathol., May 1, 2008; 61(5): 588 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Plat, I. Beugels, M. J. J. Gijbels, M. P. J. de Winther, and R. P. Mensink Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols J. Lipid Res., December 1, 2006; 47(12): 2762 - 2771. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bao, Y. Li, S.-X. Deng, D. Landry, and I. Tabas Sitosterol-containing Lipoproteins Trigger Free Sterol-induced Caspase-independent Death in ACAT-competent Macrophages J. Biol. Chem., November 3, 2006; 281(44): 33635 - 33649. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |